{
    "2020-07-10": [
        [
            {
                "time": "2020-H1",
                "orginal_text": "2020年H1疫苗批签发报告：二季度批签发环比、同比显着提升 国产13价肺炎疫苗等表现强劲",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "国产13价肺炎疫苗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "A股异动丨智飞生物(300122.SZ)涨超6%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠病毒疫苗",
                        "Ⅱ期临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "智飞生物新冠疫苗启动Ⅱ期临床试验，评估安全性与免疫原性",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "Ⅱ期临床试验",
                        "安全性",
                        "免疫原性"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "A股异动丨智飞生物(300122.SZ)涨超5%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠病毒疫苗",
                        "Ⅱ期临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "智飞生物新冠疫苗启动二期临床试验，股价创历史新高",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "二期临床试验",
                        "股价历史新高"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "智飞生物：重组新型冠状病毒疫苗启动Ⅱ期临床试验",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新型冠状病毒疫苗",
                        "Ⅱ期临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "半年报行情启动，一批预增超100%公司大涨，智飞生物启动新冠II期临床",
                "features": {
                    "keywords": [
                        "半年报",
                        "智飞生物",
                        "新冠II期临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "智飞生物重组新型冠状病毒疫苗启动Ⅱ期临床试验",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新型冠状病毒疫苗",
                        "Ⅱ期临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "orginal_text": "【行情】疫苗板块开盘异动拉升，康泰生物涨7%，达安基因、辽宁成大、沃森生物、智飞生物等跟涨",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "康泰生物",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-H1",
                "orginal_text": "【医药】2020年H1疫苗批签发：消费升级，新型疫苗渗透率持续提升——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
                "features": {
                    "keywords": [
                        "疫苗批签发",
                        "消费升级",
                        "新型疫苗",
                        "渗透率提升"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}